The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shvartsman G.I.

Mechnikov North-Western State Medical University

Skoromets A.A.

Pavlov First Saint Petersburg State Medical University

Zhivolupov S.A.

Kirov Military Medical Academy

Kurushina O.V.

Volgograd State Medical University

Karpov S.M.

Stavropol State Medical University

Baranova N.S.

Yaroslavl State Medical University

Nesterova M.V.

Ural State Medical University

Smagina I.V.

Altai State Medical University;
Regional Clinical Hospital

Prokopenko S.V.

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Antipenko E.A.

Privolzhsky Research Medical University

Novikova L.B.

Bashkir State Medical University

Therapy of moderate cognitive impairment and asthenia in patients with cerebrovascular pathology: results of a prospective observational study

Authors:

Shvartsman G.I., Skoromets A.A., Zhivolupov S.A., Kurushina O.V., Karpov S.M., Baranova N.S., Nesterova M.V., Smagina I.V., Prokopenko S.V., Antipenko E.A., Novikova L.B.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(8): 88‑94

DOI: 10.17116/jnevro202212208188

Read: 2235 times

Download PDF (RU)
Contact the author
Table of contents

THERAPY OF MODERATE COGNITIVE IMPAIRMENT AND ASTHENIA IN PATIENTS WITH CEREBROVASCULAR PATHOLOGY: RESULTS OF A PROSPECTIVE OBSERVATIONAL STUDY
THERAPY OF MODERATE COGNITIVE IMPAIRMENT AND ASTHENIA IN PATIENTS WITH CEREBROVASCULAR PATHOLOGY: RESULTS OF A PROSPECTIVE OBSERVATIONAL STUDY

To cite this article:

Shvartsman GI, Skoromets AA, Zhivolupov SA, et al. . Therapy of moderate cognitive impairment and asthenia in patients with cerebrovascular pathology: results of a prospective observational study. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(8):88‑94. (In Russ.)
https://doi.org/10.17116/jnevro202212208188

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The technology of indu­ction of physiological keto­sis in asthenia of various origins and decreased resi­stance to cognitive and physical acti­vity. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):48-54
Modern aspe­cts of chro­nic cere­bral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113
Gender aspe­cts of atte­ntion defi­cit hype­ractivity diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):70-75
Functional state of the kidneys in patients with various types of cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):105-111
Asthenia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):5-10
Cognitive impairment in asthenic diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):27-32
Characteristics of postmortem changes in the brain. Fore­nsic Medi­cal Expe­rtise. 2024;(6):56-61
The influence of neurofeedback on the β-rhythm of the brain on the characteristics of atte­ntion in athletes with different training orientations. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):20-25
Possibilities of using meldonium as part of complex therapy in patients with ischemic heart disease and chro­nic heart failure combined with obesity. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):53-60
Prevalence of cere­brovascular diseases risk factors acco­rding to the cohort survey data in Bishkek, Kyrgyz Repu­blic. Russian Journal of Preventive Medi­cine. 2025;(3):34-39
Abstract:

OBJECTIVE

Obtaining additional data on the efficacy and safety of the drug Prospekta in the treatment of moderate cognitive impairment (MCI) and asthenia in patients with cerebrovascular disease (CVD).

MATERIAL AND METHODS

A prospective observational study in more than 40 Russian cities enrolled 232 patients (mean age 61.5±10.0 years) with mild cognitive impairment (MCI), asthenia on ongoing basic nootropic therapy. The presence of MCI was confirmed by the Montreal Cognitive Assessment Scale (MoCA), asthenia — by 10-point Visual Analog Scale (VAS). All patients were prescribed the nootropic medication Prospekta 2 tablets 2 times a day for 8 weeks in addition to the therapy they received. Ultrasound Doppler sonography of the main arteries of the head and magnetic resonance imaging (MRI) of the brain were also assessed. At the end of treatment, the Clinical Global Impression Efficacy Index (CGI-EI) was assessed and the safety of the treatment was evaluated.

RESULTS

The baseline severity of cognitive impairment according to the MoCA scale was 21.6 points, severity of asthenia according to the VAS was 6.3 points. According to Doppler flowmetry findings, hemodynamically significant stenosis was revealed in 105 (49.3%) patients, and narrowing of the main vessels without changes in hemodynamic parameters was revealed in 108 (50.7%) patients. According to MRI results, single vascular lesions in the brain matter were detected in 102 (44.0%) patients. The medications with nootropic effect were administered to 144 (62.1%) patients. A positive therapeutic response as improvement of cognitive functions was seen in 93.3% of patients after 8 weeks of taking Prospekta, including 39.4% of patients who had cognitive functions restored to the normal level. No side effects were registered during the observational study.

CONCLUSIONS

The nootropic medication Prospekta is effective and safe in treatment of MCI in patients with asthenia with CVD, and improves cognitive function in patients with asthenia with CVD, both in monotherapy and in combination with other nootropic agents.

Keywords:

mild cognitive impairment
cerebrovascular disease
asthenia
brain
Prospekta

Authors:

Shvartsman G.I.

Mechnikov North-Western State Medical University

Skoromets A.A.

Pavlov First Saint Petersburg State Medical University

Zhivolupov S.A.

Kirov Military Medical Academy

Kurushina O.V.

Volgograd State Medical University

Karpov S.M.

Stavropol State Medical University

Baranova N.S.

Yaroslavl State Medical University

Nesterova M.V.

Ural State Medical University

Smagina I.V.

Altai State Medical University;
Regional Clinical Hospital

Prokopenko S.V.

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University

Antipenko E.A.

Privolzhsky Research Medical University

Novikova L.B.

Bashkir State Medical University

Received:

27.06.2022

Accepted:

04.07.2022

Close metadata

References:

  1. Russian national projects. The older generation. (in Russ). https://xn--80aapampemcchfmo7a3c9ehj.xn--p1ai/projects/demografiya/starshee_pokolenie
  2. Iadecola C, Duering M, Hachinski V, et al. Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73(25):3326-3344. https://doi.org/10.1016/j.jacc.2019.04.034
  3. Alzheimer’s Association 2018 Alzheimer’s disease facts and figures. Alzheimers Dement. 2018;14:367-429.  https://doi.org/10.1016/j.jalz.2018.02.001
  4. Gillis C, Mirzaei F, Potashman M, et al. The incidence of mild cognitive impairment: A systematic review and data synthesis. Alzheimers Dement (Amst). 2019;11:248-256.  https://doi.org/10.1016/j.dadm.2019.01.004
  5. Overton M, Pihlsgård M, Elmståhl S. Prevalence and Incidence of Mild Cognitive Impairment across Subtypes, Age, and Sex. Dement Geriatr Cogn Disord. 2019;47(4-6):219-232.  https://doi.org/10.1159/000499763
  6. Yakhno NN, Preobrazhenskaya IS, Zakharov VV. Prevalence of cognitive impairment in neurological diseases (analysis of the work of specialized outpatient admission). Neurology, Neuropsychiatry, Psychosomatics. 2012;2:30-35. (In Russ.). https://doi.org/10.14412/2074-2711-2012-378
  7. Vertkin AL. Cognitive impairment in patients with asthenia after a new coronavirus infection (COVID-19): features of occurrence and treatment approaches. The results of the observation program. Outpatient Doctor. 2022;63:1-7. (In Russ.).
  8. Bayramkulova DA, Bekishieva AR, Bijieva AI, Korkmazova AP. Features of emotional and cognitive status in patients with cerebrovascular diseases. Bulletin of Medical Internet Conferences. 2021;11(3):46-49. (In Russ.).
  9. Yusupov FA, Yuldashev AA. Neuroplasticity and possibilities of modern neurorehabilitation. Bulletin of Science and Practice. 2022;8(3):251-273. (In Russ.).
  10. Shishkova V.N. Asthenic syndrome in neurological and general therapeutic practice. Consilium Medicum. 2020;22(9):65-67. (In Russ.). https://doi.org/10.26442/20751753.2020.9.200343
  11. Fateeva VV, Vorobyeva OV, Glazunov AB. Endothelial dysfunction is a pharmacological target in the treatment of affective disorders in patients with cardiovascular diseases. Consilium Medicum. 2017;19(2.1):84-88. (In Russ.).
  12. Graff-Radford J. Vascular Cognitive Impairment. Continuum (Minneap Minn). 2019;25(1):147-164.  https://doi.org/10.1212/CON.0000000000000684
  13. Sharma MJ, Callahan BL. Cerebrovascular and Neurodegenerative Pathologies in Long-Term Stable Mild Cognitive Impairment. J Alzheimers Dis. 2021;79(3):1269-1283. https://doi.org/10.3233/JAD-200829
  14. Rundek T, Tolea M, Ariko T, et al. Vascular Cognitive Impairment (VCI). Neurotherapeutics. 2022;19(1):68-88.  https://doi.org/10.1007/s13311-021-01170-y
  15. Sharashkina NV, Ostapenko VS, Tkacheva ON, et al. Cognitive impairment in elderly and senile patients with arterial hypertension Cardiovascular Therapy and Prevention. 2017;16(3):34-38. (In Russ.). https://doi.org/10.15829/1728-8800-2017-3-34-38.
  16. Pospelova ML, Alekseeva TM, Ryzhkova DV, et al. The state of cognitive functions and brain perfusion in chronic cerebral ischemia against the background of asymptomatic carotid atherosclerosis. Modern Problems of Science and Education. 2020;6:23-29. (In Russ.).
  17. Levin OS. Pre-dement cognitive disorders in the elderly. Journal of Neurology and Psychiatry named after S.S. Korsakov. 2019;119(9;2):10-17. (In Russ.). https://doi.org/10.17116/jnevro201911909210
  18. Mackowiak-Cordoliani MA, Bombois S, Memin A, et al. Poststroke dementia in the elderly. Drugs Aging. 2005;22(6):483-93.  https://doi.org/10.2165/00002512-200522060-00003
  19. Debette S, Beiser A, DeCarli C, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke. 2010;41(4):600-6006. https://doi.org/10.1161/STROKEAHA.109.570044
  20. Voznyuk IA, Zavadenko NN, Kamchatnov PR, et al. Results of the round table: modern approaches to drug therapy of cognitive impairment in cerebrovascular pathology. Journal of Neurology and Psychiatry named after S.S. Korsakov. 2021;121(8):147-152. (In Russ.). https://doi.org/10.17116/jnevro2021121081147
  21. Instructions for the medical use of the drug Prospectus. (In Russ.). Date of appeal: 07.06.2022. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=0c47ac45-d055-4879-b8f3-bf6d2400318f
  22. Belova AN, Bogdanov EI, Voznyuk IA, et al. Therapy of moderate cognitive disorders in the early recovery period of ischemic stroke: results of a double-blind placebo-controlled randomized clinical trial. Journal of Neurology and Psychiatry named after S.S. Korsakov. 2021;121(5):33-39. (In Russ.). https://doi.org/10.17116/jnevro202112105133
  23. New technologies have made it possible to create a drug for asthenia. Medical newspaper. 2022;176(5). (In Russ.).
  24. Gudkov SV, Penkov NV, Baimer IV, et al. Effect of Mechanical Shaking on the Physicochemical Properties of Aqueous Solutions. Int J Mol Sci. 2020a;21(21):8033.
  25. Shcherbakov IA. Influence of External Impacts on the Properties of Aqueous Solutions. Physics of Wave Phenomena. 2021;29(2):89-93.  https://doi.org/10.3103/S1541308X21020114
  26. Novikov VV, Yablokova EV, Fesenko EE. The role of water in the effect of weak combined magnetic fields on production of reactive oxygen species (ROS) by neutrophils. Applied Sciences. 2020;10(9):3326. https://doi.org/10.3390/app10093326
  27. Woods KN. New insights into the microscopic interactions associated with the physical mechanism of action of highly diluted biologics. Sci Rep. 2021;11(1):13774. https://doi.org/10.1038/s41598-021-93326-1
  28. Epstein O. The spatial homeostasis hypothesis. Symmetry. 2018;10(4):103.  https://doi.org/10.3390/sym10040103
  29. Andreev F. Classical and quantum processes determine the properties of aqueous solutions. Rossiyskaya Gazeta: Special Project RG.RU. (In Russ.). Date of appeal: 06.07.2022. https://rg.ru/2021/12/23/klassicheskie-i-kvantovye-processy-opredeliaiut-svojstva-vodnyh-rastvorov.html
  30. Shcherbakov IA. Influence of external influences on the properties of aqueous solutions. Collection of abstracts of the third All-Russian conference «Physics of aqueous solutions». M.: LLC «MESOL»; 2020. (In Russ.).
  31. Kharchevsky AA. The potential of practical implementation of highly diluted solutions in engineering. Collection of abstracts of the fourth All-Russian conference «Physics of aqueous solutions». M.: LLC «MESOL»: 2021. (In Russ.).
  32. Tarasov SA, Gorbunov EA, Don ES, et al. Insights into the mechanism of action of highly diluted biologics. J Immunol. 2020;205(5):1345-1354. https://doi.org/10.4049/jimmunol.2000098
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.